Researchers from Duke University combined an FDA-approved cancer immunotherapy with gold nanostars to boost the cancer-killing abilities of both therapies, according to a study published this week in Scientific Reports.
The combination therapy cured two mice and vaccinated one against bladder cancer, the team reported.
Get the full story at our sister site, Drug Delivery Business News.